
|Podcasts|March 11, 2022
Pharmacy Focus: Psychedelic Pharmacy - Episode 5
Kelsey Ramsden, co-founder, president, and CEO at MindCure, discussed the potential links between sexual trauma and hypoactive sexual desire disorder in women.
Advertisement
In part 2 of the discussion with Kelsey Ramsden, co-founder, president, and CEO at MindCure, Ramsden discussed the potential links between sexual trauma and hypoactive sexual desire disorder in women. She also discussed how MDMA-assisted psychotherapy could help treat the disorder.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
2
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
3
IRAKLIA Trial Shows Body Weight Doesn’t Alter Outcomes With On-Body Injector Isatuximab
4
Ribociclib Plus Fulvestrant Shows Strong PFS and OS Benefits in Patients With Invasive Lobular Carcinoma
5

















































































































































































































